Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Moore

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Nature Medicine|October 6, 2020
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancerMarie Wong, Chelsea Mayoh, Loretta M S Lau, et al.
Cancer Cell|October 3, 2017
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine GliomaAlan Mackay, Anna Burford, Diana Carvalho, et al.
Cell Reports. Medicine|August 4, 2020
Pattern of Relapse and Treatment Response in WNT-Activated MedulloblastomaLiana Nobre, Michal Zapotocky, Sara Khan, et al.
Nature|September 14, 2018
The genetic basis and cell of origin of mixed phenotype acute leukaemiaThomas B Alexander, Zhaohui Gu, Ilaria Iacobucci, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very youngShunsuke Kimura, Petri Polonen, Lindsey Montefiori, et al.
The New England Journal of Medicine|September 11, 2014
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemiaKathryn G Roberts, Yongjin Li, Debbie Payne-Turner, et al.
Cancer Discovery|June 25, 2024
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High RiskShunsuke Kimura, Chun Shik Park, Lindsey E Montefiori, et al.
Cancer Cell|June 14, 2017
Intertumoral Heterogeneity within Medulloblastoma SubgroupsFlorence M G Cavalli, Marc Remke, Ladislav Rampasek, et al.
Cell|February 27, 2016
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETsDominik Sturm, Brent A Orr, Umut H Toprak, et al.
The Lancet. Oncology|March 16, 2016
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M Thompson, Thomas Hielscher, Eric Bouffet, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Nature Medicine|October 6, 2020
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancerMarie Wong, Chelsea Mayoh, Loretta M S Lau, et al.
Cancer Cell|October 3, 2017
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine GliomaAlan Mackay, Anna Burford, Diana Carvalho, et al.
Cell Reports. Medicine|August 4, 2020
Pattern of Relapse and Treatment Response in WNT-Activated MedulloblastomaLiana Nobre, Michal Zapotocky, Sara Khan, et al.
Nature|September 14, 2018
The genetic basis and cell of origin of mixed phenotype acute leukaemiaThomas B Alexander, Zhaohui Gu, Ilaria Iacobucci, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very youngShunsuke Kimura, Petri Polonen, Lindsey Montefiori, et al.
The New England Journal of Medicine|September 11, 2014
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemiaKathryn G Roberts, Yongjin Li, Debbie Payne-Turner, et al.
Cancer Discovery|June 25, 2024
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High RiskShunsuke Kimura, Chun Shik Park, Lindsey E Montefiori, et al.
Cancer Cell|June 14, 2017
Intertumoral Heterogeneity within Medulloblastoma SubgroupsFlorence M G Cavalli, Marc Remke, Ladislav Rampasek, et al.
Cell|February 27, 2016
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETsDominik Sturm, Brent A Orr, Umut H Toprak, et al.
The Lancet. Oncology|March 16, 2016
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M Thompson, Thomas Hielscher, Eric Bouffet, et al.
Pageof 9